Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity

Hypoimmunogenic human pluripotent stem cells (hPSCs) are expected to serve as an unlimited cell source for generating universally compatible “off-the-shelf” cell grafts. However, whether the engineered hypoimmunogenic hPSCs still preserve their advantages of unlimited self-renewal and multilineage d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yifan, Zhou, Yanjie, Zhou, Zhongshu, Fang, Yujiang, Ma, Lin, Zhang, Xiaoqing, Xiong, Jie, Liu, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872349/
https://www.ncbi.nlm.nih.gov/pubmed/36691086
http://dx.doi.org/10.1186/s13287-022-03233-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872349/
https://www.ncbi.nlm.nih.gov/pubmed/36691086
http://dx.doi.org/10.1186/s13287-022-03233-z

Ejemplares similares